Proctalgia fugax. Anal spasm
Conditions
Interventions
Intervention 1: Intervention Group:
To use nitroglycerin 0.2% ointment as much as a cherry core 3 times a day (every 8 hours) on pain site and intra anal for 2 weeks. Intervention 2: Control Group:
T
Treatment - Drugs
Intervention Group:
To use nitroglycerin 0.2% ointment as much as a cherry core 3 times a day (every 8 hours) on pain site and intra anal for 2 weeks.
Control Group:
To use the eucerin (placebo) as much as a cherry core 3 times a day (every 8 hours) on pain site and intra anal for 2 weeks.
Sponsors
Vice Chancellor for Research ,Kurdistan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria including: 1. Consent to participate in the study 2. Patients with recurrent episodes of severe pain localized in the lower rectum and anus area, and the episodes of pain lasting a few seconds up to 20 minutes and there was no pain between episodes. Exclusion criteria including: 1. Any proved pathology during clinical history, physical examination and rectosigmoidoscopy in anorectal including (Hemorrhoids, ischemia, anal abscess, anal fissure, rectocele, malignancy, inflammation, anal prolapsed). 2. History of trauma, urinary tract infection, surgery and hysterectomy in recent 6 months 3. Associated symptoms (fever, change in stool consistency, anemia, anal secretions, abdominal pain, weight loss and rectal bleeding). 4. History of heart and neurological disease and aortic stenosis 5. History of hypotension 6. Chronic proctalgia 7. Unwillingness to continue participating in the study 8. Single rectal ulcer
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: The second week, three months and six months after treatment. Method of measurement: Visual Analog Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The repetition of pain. Timepoint: The second week, three months and six months after treatment. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasomeh Allahmoradi
Kurdistan University of Medical Sciences
Outcome results
None listed